Influence of gut-liver axis on portal hypertension in advanced chronic liver disease: the gut microbiome as a new protagonist in therapeutic management

HIGHLIGHTS

• who: Francesco Santopaolo et al. from the Gemelli IRCCS, Rome, Italy have published the research work: Influence of Gut-Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management, in the Journal: (JOURNAL) of 10/08/2022
• what: The authors provide a reinterpretation of currently available therapeutic approaches, emphasizing their impact on the gut-liver axis. Most of the studies have been focused on hepatic encephalopathy.
• future: The increasing accessibility of complex methods of integrated metagenomics and metabolomics analysis provides a broader perspective . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.